FI951798A0 - Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina - Google Patents

Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina

Info

Publication number
FI951798A0
FI951798A0 FI951798A FI951798A FI951798A0 FI 951798 A0 FI951798 A0 FI 951798A0 FI 951798 A FI951798 A FI 951798A FI 951798 A FI951798 A FI 951798A FI 951798 A0 FI951798 A0 FI 951798A0
Authority
FI
Finland
Prior art keywords
bentzofuran
derivatives
receptor antagonists
antagonists
receptor
Prior art date
Application number
FI951798A
Other languages
English (en)
Swedish (sv)
Other versions
FI951798A (fi
Inventor
Peter Charles North
Sjoerd Nicolaas Wadman
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI951798A0 publication Critical patent/FI951798A0/fi
Publication of FI951798A publication Critical patent/FI951798A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/04Nitro compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
FI951798A 1992-10-16 1995-04-13 Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina FI951798A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929221761A GB9221761D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/002833 WO1994008993A1 (en) 1992-10-16 1993-10-14 Benzofuran derivatives as 5-ht1-like receptor antagonists

Publications (2)

Publication Number Publication Date
FI951798A0 true FI951798A0 (fi) 1995-04-13
FI951798A FI951798A (fi) 1995-04-13

Family

ID=10723562

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951798A FI951798A (fi) 1992-10-16 1995-04-13 Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina

Country Status (24)

Country Link
US (1) US5494910A (fi)
EP (1) EP0664804A1 (fi)
JP (1) JPH06211842A (fi)
KR (1) KR940009179A (fi)
CN (1) CN1092420A (fi)
AP (1) AP425A (fi)
AU (1) AU5333794A (fi)
CA (1) CA2146569A1 (fi)
CZ (1) CZ96895A3 (fi)
EC (1) ECSP941050A (fi)
FI (1) FI951798A (fi)
GB (1) GB9221761D0 (fi)
HU (1) HUT72752A (fi)
IL (1) IL107302A0 (fi)
IS (1) IS4081A (fi)
MX (1) MX9306394A (fi)
NO (1) NO951433D0 (fi)
PE (1) PE51294A1 (fi)
PL (1) PL308357A1 (fi)
RU (1) RU95110110A (fi)
SI (1) SI9300542A (fi)
TW (1) TW262473B (fi)
WO (1) WO1994008993A1 (fi)
ZA (1) ZA937633B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
EP0759918A1 (en) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB9610979D0 (en) * 1996-05-24 1996-07-31 Merck Sharp & Dohme Therapeutic agents
AU4652697A (en) * 1996-10-08 1998-05-05 Eli Lilly And Company New serotonin 5-ht1f agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
PL2734634T3 (pl) 2011-07-22 2020-03-31 The University Of Chicago Igf-1 do zastosowania do leczenia migreny
KR101443041B1 (ko) * 2013-05-06 2014-09-23 (주)하이레벤 태양광 발전설비의 효율향상설비
KR20240058859A (ko) 2021-08-12 2024-05-03 쿨레온 엘엘씨 환각성 및 비환각성 세로토닌 수용체 작용제 및 이의 제조 및 사용 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670105A1 (de) * 1966-07-08 1970-12-10 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung von Benzofuryl (3)-alkylaminen und deren Salzen
EP0398413A1 (en) * 1989-05-16 1990-11-22 Duphar International Research B.V "3,4-dehydropiperidine derivatives having psychotropic activity

Also Published As

Publication number Publication date
AP9300581A0 (en) 1993-10-31
NO951433L (no) 1995-04-12
US5494910A (en) 1996-02-27
MX9306394A (es) 1994-05-31
HU9501073D0 (en) 1995-06-28
RU95110110A (ru) 1996-12-27
CA2146569A1 (en) 1994-04-28
HUT72752A (en) 1996-05-28
KR940009179A (ko) 1994-05-20
WO1994008993A1 (en) 1994-04-28
SI9300542A (en) 1994-06-30
PE51294A1 (es) 1995-01-06
TW262473B (fi) 1995-11-11
IS4081A (is) 1994-04-17
PL308357A1 (en) 1995-07-24
AU5333794A (en) 1994-05-09
ZA937633B (en) 1994-08-01
JPH06211842A (ja) 1994-08-02
IL107302A0 (en) 1994-01-25
FI951798A (fi) 1995-04-13
GB9221761D0 (en) 1992-12-02
EP0664804A1 (en) 1995-08-02
CN1092420A (zh) 1994-09-21
CZ96895A3 (en) 1995-12-13
NO951433D0 (no) 1995-04-12
ECSP941050A (es) 1994-11-16
AP425A (en) 1995-11-08

Similar Documents

Publication Publication Date Title
DK0533268T3 (da) Benzanilidderivater som 5HT-1D antagonister
DK0630376T3 (da) Kondenserede indolderivater som 5-HT4-receptorantagonister
NO940974D0 (no) Benzanilid-derivater som 5-HT1D antagonister
DK0804419T3 (da) Quinolinderivater som tachykinin NK 3-receptor-antagonister
DK0514667T3 (da) Benzazepinderivater som vasopressinantagonister
DE69207351T2 (de) Fibrinogen-Rezeptor-Antagoniste
NO981477D0 (no) Pyrimidinderivater som 5HT2C-reseptor antagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
NO985225L (no) Indolderivater nyttige som endotelinreseptorantagonister
FI961628A0 (fi) Indolijohdannaisia NMDA-antagonisteina
KR950703530A (ko) 5-HT4 길항제(5-HT4 Antagonists)
NO974043L (no) Indolderivater som EAA-antagonister
NO20002036D0 (no) Cyklopentenderivater nyttig som antagonister for motilinreseptoren
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO985970D0 (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO179550C (no) Tachykinin reseptorantagonister
NO985972L (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
FI943513A (fi) Kolekystokiniiniantagonisteina käyttökelpoisia 3-fenyyliureidoatsepin-2-oneja ja -bentsatsepin-2-oneja
NO974205L (no) Heterocyklisk-substituerte piperazinonderivater som tachykininreceptor-antagonister
FI943872A0 (fi) 2,6-metano-2H-kinditsiinijohdannainen 5-HT3-reseptoriantagonistina
FI940607A0 (fi) Imidatso(5,1-C)(1,4)bentsoksatsin-1-onijohdannaiset 5HT3-antagonisteina
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
FI941117A0 (fi) Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina
DK0660832T3 (da) Serotoninreceptor-midler